SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-227653
Filing Date
2012-05-11
Accepted
2012-05-11 12:30:25
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d330877d10q.htm 10-Q 252827
2 OFFER LETTER TO DAVID L. JOHNSON d330877dex101.htm EX-10.1 30686
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER REQUIRED BY SECTION 302 d330877dex311.htm EX-31.1 6926
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER REQUIRED BY SECTION 302 d330877dex312.htm EX-31.2 6919
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER SECTION 906 d330877dex321.htm EX-32.1 5417
  Complete submission text file 0001193125-12-227653.txt   1100908

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxgn-20120331.xml EX-101.INS 93204
7 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20120331.xsd EX-101.SCH 7283
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20120331_cal.xml EX-101.CAL 21284
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20120331_lab.xml EX-101.LAB 74107
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20120331_pre.xml EX-101.PRE 48259
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 12833141
SIC: 2836 Biological Products, (No Diagnostic Substances)